Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: May 25, 2011


RainDance Technologies said yesterday that it has appointed Andy Watson as vice president and chief marketing officer. Watson will lead RainDance's global marketing and strategy efforts to grow the current commercial targeted sequencing business and prepare the market for the launch of its digital PCR and single-cell analysis products.

Watson joins RainDance from Life Technologies, where he was most recently vice president of SOLiD sequencing product management. Previously, he led Applied Biosystems' (now part of Life Technologies) capillary electrophoresis sequencing business, including instruments, reagents, and software.

Before joining Applied Biosystems, Watson helped found Quantum Dot (acquired by Invitrogen and now part of Life Technologies), where he held executive technical and business management roles. He also led the development of technologies and software for large-scale DNA analysis at Sequana Therapeutics (acquired by Celera); and the Wellcome Trust Sanger Institute.

Watson holds MEng, MA, and BA degrees from King's College, Cambridge University.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.